These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1033 related articles for article (PubMed ID: 17925561)
1. Disclosure of conflicts of interest by authors of clinical trials and editorials in oncology. Riechelmann RP; Wang L; O'Carroll A; Krzyzanowska MK J Clin Oncol; 2007 Oct; 25(29):4642-7. PubMed ID: 17925561 [TBL] [Abstract][Full Text] [Related]
2. Frequency, nature, effects, and correlates of conflicts of interest in published clinical cancer research. Jagsi R; Sheets N; Jankovic A; Motomura AR; Amarnath S; Ubel PA Cancer; 2009 Jun; 115(12):2783-91. PubMed ID: 19434666 [TBL] [Abstract][Full Text] [Related]
3. Self-reported conflicts of interest of authors, trial sponsorship, and the interpretation of editorials and related phase III trials in oncology. Bariani GM; de Celis Ferrari AC; Hoff PM; Krzyzanowska MK; Riechelmann RP J Clin Oncol; 2013 Jun; 31(18):2289-95. PubMed ID: 23630201 [TBL] [Abstract][Full Text] [Related]
4. Disclosure of financial conflicts of interest by authors publishing in the Journal of Clinical Oncology. Go RS; Mathiason MA; Lee JA J Clin Oncol; 2008 Jan; 26(3):509-10; author reply 510-1. PubMed ID: 18202429 [No Abstract] [Full Text] [Related]
5. Do financial factors such as author page charges and industry funding impact on the nature of published research in infectious diseases? Liyanage SS; Raina Macintyre C Health Info Libr J; 2006 Sep; 23(3):214-22. PubMed ID: 16911128 [TBL] [Abstract][Full Text] [Related]
6. Funding source and conflict of interest disclosures by authors and editors in gastroenterology specialty journals. Bhargava N; Qureshi J; Vakil N Am J Gastroenterol; 2007 Jun; 102(6):1146-50. PubMed ID: 17531007 [TBL] [Abstract][Full Text] [Related]
7. Association between pharmaceutical involvement and outcomes in breast cancer clinical trials. Peppercorn J; Blood E; Winer E; Partridge A Cancer; 2007 Apr; 109(7):1239-46. PubMed ID: 17326054 [TBL] [Abstract][Full Text] [Related]
8. Industry sponsorship and authorship of clinical trials over 20 years. Buchkowsky SS; Jewesson PJ Ann Pharmacother; 2004 Apr; 38(4):579-85. PubMed ID: 14982982 [TBL] [Abstract][Full Text] [Related]
9. Authors of clinical trials reported individual and financial conflicts of interest more frequently than institutional and nonfinancial ones: a methodological survey. Hakoum MB; Jouni N; Abou-Jaoude EA; Hasbani DJ; Abou-Jaoude EA; Lopes LC; Khaldieh M; Hammoud MZ; Al-Gibbawi M; Anouti S; Guyatt G; Akl EA J Clin Epidemiol; 2017 Jul; 87():78-86. PubMed ID: 28412465 [TBL] [Abstract][Full Text] [Related]
10. Attitudes toward research participation and investigator conflicts of interest among advanced cancer patients participating in early phase clinical trials. Gray SW; Hlubocky FJ; Ratain MJ; Daugherty CK J Clin Oncol; 2007 Aug; 25(23):3488-94. PubMed ID: 17687154 [TBL] [Abstract][Full Text] [Related]
11. Reporting of conflicts of interest in meta-analyses of trials of pharmacological treatments. Roseman M; Milette K; Bero LA; Coyne JC; Lexchin J; Turner EH; Thombs BD JAMA; 2011 Mar; 305(10):1008-17. PubMed ID: 21386079 [TBL] [Abstract][Full Text] [Related]
12. Association of industry sponsorship to published outcomes in gastrointestinal clinical research. Brown A; Kraft D; Schmitz SM; Sharpless V; Martin C; Shah R; Shaheen NJ Clin Gastroenterol Hepatol; 2006 Dec; 4(12):1445-51. PubMed ID: 17101295 [TBL] [Abstract][Full Text] [Related]
13. The prevalence and influence of self-reported conflicts of interest by editorial authors of phase III cancer trials. Lerner TG; Miranda Mda C; Lera AT; Ueda A; Briones B; Del Giglio A; Riechelmann R Contemp Clin Trials; 2012 Sep; 33(5):1019-22. PubMed ID: 22664644 [TBL] [Abstract][Full Text] [Related]
14. Increasingly conflicted: an analysis of conflicts of interest reported at the annual meetings of the Orthopaedic Trauma Association. Kubiak EN; Park SS; Egol K; Zuckerman JD; Koval KJ Bull Hosp Jt Dis; 2006; 63(3-4):83-7. PubMed ID: 16878823 [TBL] [Abstract][Full Text] [Related]
15. Assessment by human research ethics committees of potential conflicts of interest arising from pharmaceutical sponsorship of clinical research. Newcombe JP; Kerridge IH Intern Med J; 2007 Jan; 37(1):12-7. PubMed ID: 17199839 [TBL] [Abstract][Full Text] [Related]
16. Survey of conflict-of-interest disclosure policies of ophthalmology journals. Anraku A; Jin YP; Trope GE; Buys YM Ophthalmology; 2009 Jun; 116(6):1093-6. PubMed ID: 19376583 [TBL] [Abstract][Full Text] [Related]
17. Conflicts of interest in oncology expanded access studies. Borysowski J; Lewis ACF; Górski A Int J Cancer; 2021 Nov; 149(10):1809-1816. PubMed ID: 34233015 [TBL] [Abstract][Full Text] [Related]
18. Reporting of Financial and Non-financial Conflicts of Interest in Systematic Reviews on Health Policy and Systems Research: A Cross Sectional Survey. Bou-Karroum L; Hakoum MB; Hammoud MZ; Khamis AM; Al-Gibbawi M; Badour S; Justina Hasbani D; Cruz Lopes L; El-Rayess HM; El-Jardali F; Guyatt G; Akl EA Int J Health Policy Manag; 2018 Aug; 7(8):711-717. PubMed ID: 30078291 [TBL] [Abstract][Full Text] [Related]
19. Conflict of interest in oncology publications: a survey of disclosure policies and statements. Kesselheim AS; Lee JL; Avorn J; Servi A; Shrank WH; Choudhry NK Cancer; 2012 Jan; 118(1):188-95. PubMed ID: 21717432 [TBL] [Abstract][Full Text] [Related]
20. Extent and impact of industry sponsorship conflicts of interest in dermatology research. Perlis CS; Harwood M; Perlis RH J Am Acad Dermatol; 2005 Jun; 52(6):967-71. PubMed ID: 15928613 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]